Cargando…

Predictive markers for Parkinson's disease using deep neural nets on neuromelanin sensitive MRI

Neuromelanin sensitive magnetic resonance imaging (NMS-MRI) has been crucial in identifying abnormalities in the substantia nigra pars compacta (SNc) in Parkinson's disease (PD) as PD is characterized by loss of dopaminergic neurons in the SNc. Current techniques employ estimation of contrast r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shinde, Sumeet, Prasad, Shweta, Saboo, Yash, Kaushick, Rishabh, Saini, Jitender, Pal, Pramod Kumar, Ingalhalikar, Madhura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417260/ https://www.ncbi.nlm.nih.gov/pubmed/30870733 http://dx.doi.org/10.1016/j.nicl.2019.101748

Ejemplares similares

Microstructural abnormalities of substantia nigra in Parkinson's disease: A neuromelanin sensitive MRI atlas based study
por: Safai, Apoorva, et al.
Publicado: (2019)

Multimodal Brain Connectomics-Based Prediction of Parkinson’s Disease Using Graph Attention Networks
por: Safai, Apoorva, et al.
Publicado: (2022)

Predictive and discriminative localization of pathology using high resolution class activation maps with CNNs
por: Shinde, Sumeet, et al.
Publicado: (2021)

NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson’s disease using convolutional neural network
por: Gaurav, Rahul, et al.
Publicado: (2022)

Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker
por: Gaurav, Rahul, et al.
Publicado: (2021)

Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease
por: Vila, Miquel
Publicado: (2019)

An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson’s disease using neuromelanin-sensitive MRI
por: Liu, Qiang, et al.
Publicado: (2023)

Developing a Radiomics Signature for Supratentorial Extra-Ventricular Ependymoma Using Multimodal MR Imaging
por: Safai, Apoorva, et al.
Publicado: (2021)

Neuromelanin‐MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template‐Based Standardized Analysis
por: Xing, Yue, et al.
Publicado: (2022)

Locus coeruleus and substantia nigra neuromelanin magnetic resonance imaging differentiates Parkinson’s disease and essential tremor
por: Wang, Xinhui, et al.
Publicado: (2023)

Fronto-striato-thalamic circuit connectivity and neuromelanin in schizophrenia: an fMRI and neuromelanin-MRI study
por: Choi, Sunah, et al.
Publicado: (2023)

Deep Learning‐Based Neuromelanin MRI Changes of Isolated REM Sleep Behavior Disorder
por: Gaurav, Rahul, et al.
Publicado: (2022)

Neuromelanin related ultra-high field signal intensity of the locus coeruleus differs between Parkinson’s disease and controls
por: Wolters, Amée F., et al.
Publicado: (2023)

Abnormal Subcortical Volumes and Cortical Thickness in Parkinson's Disease with Impulse Control Disorders
por: Prasad, Shweta, et al.
Publicado: (2019)

Neuromelanin and T(2)*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
por: Ben Bashat, Dafna, et al.
Publicado: (2022)

Unraveling the contributions to the neuromelanin-MRI contrast
por: Priovoulos, Nikos, et al.
Publicado: (2020)

The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson’s disease
por: Nagatsu, Toshiharu, et al.
Publicado: (2023)

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
por: Isaias, Ioannis U., et al.
Publicado: (2016)

Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase
por: Nagatsu, Toshiharu, et al.
Publicado: (2022)

Application of Neuromelanin MR Imaging in Parkinson Disease
por: He, Naying, et al.
Publicado: (2022)

Neuromelanin-sensitive MRI correlates of cognitive and motor function in Parkinson’s disease with freezing of gait
por: Huddleston, Daniel E., et al.
Publicado: (2023)

Nigrosome and Neuromelanin Imaging as Tools to Differentiate Parkinson's Disease and Parkinsonism
por: Biswas, Deblina, et al.
Publicado: (2022)

Neuromelanin‐Sensitive Magnetic Resonance Imaging Using DANTE Pulse
por: Oshima, Sonoko, et al.
Publicado: (2020)

Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson’s disease
por: Sulzer, David, et al.
Publicado: (2018)

Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
por: Xu, Shengli, et al.
Publicado: (2015)

Structural anomaly in the reticular formation in narcolepsy type 1, suggesting lower levels of neuromelanin
por: Drissi, Natasha Morales, et al.
Publicado: (2019)

Convolutional neural network-based segmentation can help in assessing the substantia nigra in neuromelanin MRI
por: Le Berre, Alice, et al.
Publicado: (2019)

Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI
por: Depierreux, Frédérique, et al.
Publicado: (2021)

Brainstem neuromelanin and iron MRI reveals a precise signature for idiopathic and LRRK2 Parkinson’s disease
por: Martínez, Martín, et al.
Publicado: (2023)

The protective and toxic role of neuromelanins in brain aging and Parkinson’s disease
por: Zecca, Luigi, et al.
Publicado: (2015)

The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease
por: Biondetti, Emma, et al.
Publicado: (2021)

Corrigendum to: Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson’s disease
Publicado: (2020)

A New Statistical Framework for Corpus Callosum Sub-Region Characterization Based on LBP Texture in Patients With Parkinsonian Disorders: A Pilot Study
por: Bhattacharya, Debanjali, et al.
Publicado: (2020)

Acceleration of neuromelanin-sensitive MRI sequences in the substantia nigra using standard MRI options
por: van der Pluijm, Marieke, et al.
Publicado: (2022)

Early‐stage Parkinson's disease: Abnormal nigrosome 1 and 2 revealed by a voxelwise analysis of neuromelanin‐sensitive MRI
por: Sung, Young Hee, et al.
Publicado: (2021)

Neuromelanin or DaT‐SPECT: which is the better marker for discriminating advanced Parkinson's disease?
por: Okuzumi, A., et al.
Publicado: (2019)

In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson’s disease
por: Gonzalez-Sepulveda, Marta, et al.
Publicado: (2023)

Iron- and Neuromelanin-Weighted Neuroimaging to Study Mitochondrial Dysfunction in Patients with Parkinson’s Disease
por: Pizarro-Galleguillos, Benjamin Matis, et al.
Publicado: (2022)

Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease
por: Riederer, Peter, et al.
Publicado: (2023)

Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role
por: Zucca, Fabio A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jldtk3fil6jke7aprh8s1cd6nb